Article
Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum.
The Biochemical journal - 1 Nov 2012
Nuttall James M, Hettema Ewald H, Watts Donald J
Abstract excerpt
NBP (nitrogen-containing bisphosphonate) drugs protect against excessive osteoclast-mediated bone resorption. After binding to bone mineral, they are taken up selectively by the osteoclasts and inhibit the essential enzyme FDPS (farnesyl diphosphate synthase). NBPs inhibit also growth of amoebae of Dictyostelium discoideum in which their target is again FDPS. A fusion protein between FDPS and GFP (green...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
